Off-topic for aiqbench
This story was gathered from a source we follow but falls outside AI and quantum coverage, so there is no aiqbench take for it.
Lakewood-Amedex lists on Nasdaq with $7.5M raise, advances antimicrobial Nu-3 to Phase 2a trial
Dealroom.co1 min read
Lakewood-Amedex lists on Nasdaq with $7.5M raise, advances antimicrobial Nu-3 to Phase 2a trial Dealroom
Read the full article at Dealroom.co
